{"title":"Comparison of Topical Treatment Preferences of Physicians in Dermatological Diseases","authors":"Hasan Aksoy, Melek Aslan Kayıran, Hümeyra Özger","doi":"10.58600/eurjther1859","DOIUrl":null,"url":null,"abstract":"Objective: Regardless of their specialty, physicians frequently encounter dermatological conditions. We aimed to determine the topical medication choices of physicians for various dermatoses and to identify differences in preferences between dermatologists and non-dermatologist physicians.
 Methods: Using an online survey, physicians were asked to select three preferred topical antibiotics/antiseptics, antifungals, and corticosteroids when treating a pyoderma, dermatophytosis, or a dermatosis necessitating topical corticosteroid therapy. Statistical analysis was performed using Statistical Package for the Social Sciences v.27.
 Results: Among 358 physicians, 24.0% were dermatologists, and 76.0% were non-dermatologist physicians. The mean age was 38.40, and the average duration of medical practice was 14.04 years. The most frequently chosen topical antibacterials were fusidic acid (74.3%) and mupirocin (65.9%); topical antifungals were isoconazole nitrate + diflucortolone valerate (56.4%), tioconazole (27.7%), and naftifine (25.1%); and topical corticosteroids were clobetasol propionate (38.5%), methylprednisolone aceponate (36.6%), and mometasone furoate (34.6%). Dermatologists used nitrofurazone and izokonazol nitrate + diflucortolone valerate less frequently compared to non-dermatologists (0% vs. 27.6% and 8.1% vs. 71.7%, respectively; p-values <0.001). Family physicians/general practitioners constituted the largest group selecting clobetasol propionate (28.3%).
 Conclusion: Physicians in our country predominantly choose fusidic acid and mupirocin as topical antibiotics, aligning with existing literature. However, nitrofurazone, causing contact dermatitis, and corticosteroid-containing antifungals with the potential for complications due to inappropriate use are frequently preferred by non-dermatologist physicians but not by dermatologists. The bold choice of clobetasol propionate, an ultrapotent topical corticosteroid, by family physicians/general practitioners is an important issue to address during medical education and post-graduation.","PeriodicalId":42642,"journal":{"name":"European Journal of Therapeutics","volume":"129 1","pages":"0"},"PeriodicalIF":0.3000,"publicationDate":"2023-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58600/eurjther1859","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Regardless of their specialty, physicians frequently encounter dermatological conditions. We aimed to determine the topical medication choices of physicians for various dermatoses and to identify differences in preferences between dermatologists and non-dermatologist physicians.
Methods: Using an online survey, physicians were asked to select three preferred topical antibiotics/antiseptics, antifungals, and corticosteroids when treating a pyoderma, dermatophytosis, or a dermatosis necessitating topical corticosteroid therapy. Statistical analysis was performed using Statistical Package for the Social Sciences v.27.
Results: Among 358 physicians, 24.0% were dermatologists, and 76.0% were non-dermatologist physicians. The mean age was 38.40, and the average duration of medical practice was 14.04 years. The most frequently chosen topical antibacterials were fusidic acid (74.3%) and mupirocin (65.9%); topical antifungals were isoconazole nitrate + diflucortolone valerate (56.4%), tioconazole (27.7%), and naftifine (25.1%); and topical corticosteroids were clobetasol propionate (38.5%), methylprednisolone aceponate (36.6%), and mometasone furoate (34.6%). Dermatologists used nitrofurazone and izokonazol nitrate + diflucortolone valerate less frequently compared to non-dermatologists (0% vs. 27.6% and 8.1% vs. 71.7%, respectively; p-values <0.001). Family physicians/general practitioners constituted the largest group selecting clobetasol propionate (28.3%).
Conclusion: Physicians in our country predominantly choose fusidic acid and mupirocin as topical antibiotics, aligning with existing literature. However, nitrofurazone, causing contact dermatitis, and corticosteroid-containing antifungals with the potential for complications due to inappropriate use are frequently preferred by non-dermatologist physicians but not by dermatologists. The bold choice of clobetasol propionate, an ultrapotent topical corticosteroid, by family physicians/general practitioners is an important issue to address during medical education and post-graduation.
目的:无论他们的专业是什么,医生经常会遇到皮肤病。我们的目的是确定医生对各种皮肤病的局部用药选择,并确定皮肤科医生和非皮肤科医生之间偏好的差异。
方法:通过在线调查,医生被要求在治疗脓皮病、皮肤病或需要局部皮质类固醇治疗的皮肤病时,选择三种首选的局部抗生素/防腐剂、抗真菌药和皮质类固醇。使用Statistical Package for the Social Sciences v.27.
进行统计分析;结果:358名医师中皮肤科医师占24.0%,非皮肤科医师占76.0%。平均年龄38.40岁,平均执业时间14.04年。最常选择的外用抗菌药物是福西地酸(74.3%)和莫匹罗星(65.9%);外用抗真菌药物为硝酸异康唑+戊酸双氟落酮(56.4%)、噻康唑(27.7%)和纳替芬(25.1%);外用皮质类固醇为丙酸氯倍他索(38.5%)、乙酰甲泼尼龙(36.6%)和糠酸莫米松(34.6%)。与非皮肤科医生相比,皮肤科医生使用硝基呋喃酮和硝酸异康唑+戊酸双氟落酮的频率较低(分别为0%对27.6%和8.1%对71.7%;假定值& lt; 0.001)。家庭医生/全科医生是选择丙酸氯倍他索的最大群体(28.3%)。
结论:我国内科医生主要选择夫西地酸和莫匹罗星作为外用抗生素,与已有文献一致。然而,引起接触性皮炎的硝基呋喃酮和含有皮质类固醇的抗真菌药物,由于使用不当可能导致并发症,通常是非皮肤科医生的首选,而不是皮肤科医生的首选。家庭医生/全科医生大胆选择丙酸氯倍他索(一种超强效外用皮质类固醇)是医学教育和毕业后需要解决的一个重要问题。